Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	extracellular matrix structural constituent	NID2 COLQ SLIT2 FBN2 IGFBP7 MUC5AC FBN3	1.42e-04	188	120	7	GO:0005201
GeneOntologyMolecularFunction	insulin-like growth factor binding	IGFBP7 LRP2 KAZALD1	1.91e-04	19	120	3	GO:0005520
GeneOntologyMolecularFunction	death receptor activity	TNFRSF10D NGFR TNFRSF19	2.60e-04	21	120	3	GO:0005035
GeneOntologyMolecularFunction	growth factor binding	FLT4 SORT1 IGFBP7 NGFR LRP2 KAZALD1	3.62e-04	156	120	6	GO:0019838
GeneOntologyMolecularFunction	protein-lysine N-methyltransferase activity	METTL13 KMT5B KMT2A SETD7	7.51e-04	68	120	4	GO:0016279
GeneOntologyMolecularFunction	lysine N-methyltransferase activity	METTL13 KMT5B KMT2A SETD7	7.93e-04	69	120	4	GO:0016278
GeneOntologyMolecularFunction	structural molecule activity	NID2 MAP1B TUBB OBSCN TUBB2B COLQ TUBB2A SLIT2 FBN2 IGFBP7 JAG1 MUC5AC FBN3 EPB41L2	9.28e-04	891	120	14	GO:0005198
GeneOntologyMolecularFunction	histone H3K4 monomethyltransferase activity	KMT2A SETD7	9.79e-04	8	120	2	GO:0140945
GeneOntologyMolecularFunction	nerve growth factor binding	SORT1 NGFR	9.79e-04	8	120	2	GO:0048406
GeneOntologyMolecularFunction	protein kinase activity	FLT4 TRIB2 PIM2 OBSCN SRPK2 TEX14 SRPK3 MST1L RIOK2 EIF2AK3 TRIB1	9.91e-04	600	120	11	GO:0004672
GeneOntologyCellularComponent	cell surface	CACNA1D NID2 CD248 HLA-DQA1 HLA-DQA2 COLEC10 TNFRSF10D APOH CR1 SORT1 SLIT2 KCNA4 KCNH1 CLPTM1 NGFR LRP2 ADAM2 KCNH5 GP2	1.84e-05	1111	120	19	GO:0009986
GeneOntologyCellularComponent	extracellular matrix	NID2 ADAMTSL1 CD248 APOH COLQ SLIT2 SSC5D FBN2 IGFBP7 KAZALD1 MUC5AC FBN3	3.96e-04	656	120	12	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	NID2 ADAMTSL1 CD248 APOH COLQ SLIT2 SSC5D FBN2 IGFBP7 KAZALD1 MUC5AC FBN3	4.07e-04	658	120	12	GO:0030312
Domain	EGF_Ca-bd_CS	NID2 CD248 LRP1B SLIT2 FBN2 JAG1 LRP2 FBN3	2.20e-07	97	121	8	IPR018097
Domain	EGF_CA	NID2 CD248 LRP1B SLIT2 FBN2 JAG1 LRP2 FBN3	2.57e-07	99	121	8	PS01187
Domain	EGF_3	NID2 CD248 CNTNAP1 LRP1B SLIT2 FBN2 JAG1 LRP2 ADAM2 FBN3 GP2	3.75e-07	235	121	11	PS50026
Domain	EGF-type_Asp/Asn_hydroxyl_site	NID2 CD248 LRP1B SLIT2 FBN2 JAG1 LRP2 FBN3	4.36e-07	106	121	8	IPR000152
Domain	cEGF	NID2 LRP1B FBN2 LRP2 FBN3	6.20e-07	26	121	5	PF12662
Domain	cEGF	NID2 LRP1B FBN2 LRP2 FBN3	6.20e-07	26	121	5	IPR026823
Domain	Growth_fac_rcpt_	NID2 CD248 LRP1B FBN2 IGFBP7 JAG1 LRP2 KAZALD1 FBN3	7.99e-07	156	121	9	IPR009030
Domain	EGF_2	NID2 CD248 CNTNAP1 LRP1B SLIT2 FBN2 JAG1 LRP2 ADAM2 FBN3 GP2	1.23e-06	265	121	11	PS01186
Domain	EGF_CA	NID2 CD248 LRP1B SLIT2 FBN2 JAG1 LRP2 FBN3	1.28e-06	122	121	8	SM00179
Domain	EGF_CA	NID2 CD248 LRP1B FBN2 JAG1 LRP2 FBN3	1.42e-06	86	121	7	PF07645
Domain	EGF-like_Ca-bd_dom	NID2 CD248 LRP1B SLIT2 FBN2 JAG1 LRP2 FBN3	1.45e-06	124	121	8	IPR001881
Domain	EGF	NID2 CD248 CNTNAP1 LRP1B SLIT2 JAG1 LRP2 FBN3	1.63e-06	126	121	8	PF00008
Domain	ASX_HYDROXYL	NID2 LRP1B SLIT2 FBN2 JAG1 LRP2 FBN3	3.91e-06	100	121	7	PS00010
Domain	EGF-like_dom	NID2 CD248 CNTNAP1 LRP1B SLIT2 FBN2 JAG1 LRP2 FBN3 GP2	5.13e-06	249	121	10	IPR000742
Domain	EGF_1	CD248 CNTNAP1 LRP1B SLIT2 FBN2 JAG1 LRP2 ADAM2 FBN3 GP2	6.33e-06	255	121	10	PS00022
Domain	EGF-like_CS	NID2 CD248 CNTNAP1 LRP1B SLIT2 FBN2 JAG1 LRP2 FBN3 GP2	7.76e-06	261	121	10	IPR013032
Domain	EGF	NID2 CD248 CNTNAP1 LRP1B SLIT2 FBN2 JAG1 LRP2 FBN3	2.26e-05	235	121	9	SM00181
Domain	hEGF	SLIT2 FBN2 JAG1 FBN3	3.04e-05	28	121	4	PF12661
Domain	Beta-tubulin_BS	TUBB TUBB2B TUBB2A	3.08e-05	10	121	3	IPR013838
Domain	Beta_tubulin	TUBB TUBB2B TUBB2A	3.08e-05	10	121	3	IPR002453
Domain	K_chnl_volt-dep_EAG	KCNH1 KCNH5	4.16e-05	2	121	2	IPR003949
Domain	TUBULIN_B_AUTOREG	TUBB TUBB2B TUBB2A	4.21e-05	11	121	3	PS00228
Domain	Ldl_recept_b	NID2 LRP1B LRP2	9.16e-05	14	121	3	PF00058
Domain	LDLRB	NID2 LRP1B LRP2	9.16e-05	14	121	3	PS51120
Domain	LY	NID2 LRP1B LRP2	1.14e-04	15	121	3	SM00135
Domain	LDLR_classB_rpt	NID2 LRP1B LRP2	1.14e-04	15	121	3	IPR000033
Domain	FBN	FBN2 FBN3	1.24e-04	3	121	2	IPR011398
Domain	IGFBP_rP_mac25	IGFBP7 KAZALD1	1.24e-04	3	121	2	IPR011390
Domain	Tribbles/Ser_Thr_kinase_40	TRIB2 TRIB1	2.48e-04	4	121	2	IPR024104
Domain	-	TUBB TUBB2B TUBB2A	2.79e-04	20	121	3	3.30.1330.20
Domain	-	TUBB TUBB2B TUBB2A	3.24e-04	21	121	3	1.10.287.600
Domain	Tubulin_C	TUBB TUBB2B TUBB2A	3.73e-04	22	121	3	PF03953
Domain	Tubulin/FtsZ_2-layer-sand-dom	TUBB TUBB2B TUBB2A	3.73e-04	22	121	3	IPR018316
Domain	-	TUBB TUBB2B TUBB2A	3.73e-04	22	121	3	3.40.50.1440
Domain	Tubulin_C	TUBB TUBB2B TUBB2A	3.73e-04	22	121	3	SM00865
Domain	TNFR_c6	TNFRSF10D NGFR TNFRSF19	3.73e-04	22	121	3	PF00020
Domain	C1-set_C	HLA-DQA1 HLA-DQA2	4.11e-04	5	121	2	PF16196
Domain	MHC_II_alpha	HLA-DQA1 HLA-DQA2	4.11e-04	5	121	2	SM00920
Domain	C1-set_C	HLA-DQA1 HLA-DQA2	4.11e-04	5	121	2	IPR032431
Domain	Tub_FtsZ_C	TUBB TUBB2B TUBB2A	4.27e-04	23	121	3	IPR008280
Domain	Tubulin_C	TUBB TUBB2B TUBB2A	4.27e-04	23	121	3	IPR023123
Domain	TUBULIN	TUBB TUBB2B TUBB2A	4.27e-04	23	121	3	PS00227
Domain	Tubulin	TUBB TUBB2B TUBB2A	4.27e-04	23	121	3	IPR000217
Domain	Tubulin	TUBB TUBB2B TUBB2A	4.27e-04	23	121	3	SM00864
Domain	Tubulin_CS	TUBB TUBB2B TUBB2A	4.27e-04	23	121	3	IPR017975
Domain	Tubulin_FtsZ_GTPase	TUBB TUBB2B TUBB2A	4.86e-04	24	121	3	IPR003008
Domain	Tubulin	TUBB TUBB2B TUBB2A	4.86e-04	24	121	3	PF00091
Domain	MHC_II_alpha	HLA-DQA1 HLA-DQA2	6.14e-04	6	121	2	PF00993
Domain	TNFR	TNFRSF10D NGFR TNFRSF19	6.18e-04	26	121	3	SM00208
Domain	TB	FBN2 FBN3	8.56e-04	7	121	2	PF00683
Domain	MHC_II_a_N	HLA-DQA1 HLA-DQA2	8.56e-04	7	121	2	IPR001003
Domain	TNFR_NGFR_1	TNFRSF10D NGFR TNFRSF19	8.57e-04	29	121	3	PS00652
Domain	TNFR_NGFR_2	TNFRSF10D NGFR TNFRSF19	8.57e-04	29	121	3	PS50050
Domain	-	FBN2 FBN3	1.14e-03	8	121	2	3.90.290.10
Domain	TNFR/NGFR_Cys_rich_reg	TNFRSF10D NGFR TNFRSF19	1.26e-03	33	121	3	IPR001368
Domain	Prot_kinase_dom	FLT4 TRIB2 PIM2 OBSCN SRPK2 TEX14 SRPK3 RIOK2 EIF2AK3 TRIB1	1.31e-03	489	121	10	IPR000719
Domain	PROTEIN_KINASE_DOM	FLT4 TRIB2 PIM2 OBSCN SRPK2 TEX14 SRPK3 RIOK2 EIF2AK3 TRIB1	1.39e-03	493	121	10	PS50011
Domain	TB_dom	FBN2 FBN3	1.45e-03	9	121	2	IPR017878
Domain	TB	FBN2 FBN3	1.45e-03	9	121	2	PS51364
Domain	PAS_9	KCNH1 KCNH5	1.81e-03	10	121	2	PF13426
Domain	-	NID2 LRP1B LRP2	2.04e-03	39	121	3	2.120.10.30
Domain	SET	KMT5B KMT2A SETD7	2.36e-03	41	121	3	PF00856
Domain	Kinase-like_dom	FLT4 TRIB2 PIM2 OBSCN SRPK2 TEX14 SRPK3 RIOK2 EIF2AK3 TRIB1	2.77e-03	542	121	10	IPR011009
Domain	SET	KMT5B KMT2A SETD7	3.29e-03	46	121	3	SM00317
Domain	6-blade_b-propeller_TolB-like	NID2 LRP1B LRP2	3.29e-03	46	121	3	IPR011042
Domain	MHC_II_a/b_N	HLA-DQA1 HLA-DQA2	3.60e-03	14	121	2	IPR014745
Domain	TIL_dom	LRP2 MUC5AC	3.60e-03	14	121	2	IPR002919
Domain	P_typ_ATPase_c	ATP8B4 ATP8B2	3.60e-03	14	121	2	IPR032630
Domain	P-type_ATPase_N	ATP8B4 ATP8B2	3.60e-03	14	121	2	IPR032631
Domain	P-type_ATPase_IV	ATP8B4 ATP8B2	3.60e-03	14	121	2	IPR006539
Domain	K_chnl_volt-dep_EAG/ELK/ERG	KCNH1 KCNH5	3.60e-03	14	121	2	IPR003938
Domain	-	HLA-DQA1 HLA-DQA2	3.60e-03	14	121	2	3.10.320.10
Domain	PhoLip_ATPase_C	ATP8B4 ATP8B2	3.60e-03	14	121	2	PF16212
Domain	PhoLip_ATPase_N	ATP8B4 ATP8B2	3.60e-03	14	121	2	PF16209
Domain	SET_dom	KMT5B KMT2A SETD7	4.16e-03	50	121	3	IPR001214
Domain	SET	KMT5B KMT2A SETD7	4.16e-03	50	121	3	PS50280
Domain	Kringle_CS	PRSS12 MST1L	5.31e-03	17	121	2	IPR018056
Domain	KRINGLE_1	PRSS12 MST1L	5.31e-03	17	121	2	PS00021
Domain	KR	PRSS12 MST1L	5.31e-03	17	121	2	SM00130
Domain	Kringle	PRSS12 MST1L	5.31e-03	17	121	2	IPR000001
Domain	KRINGLE_2	PRSS12 MST1L	5.31e-03	17	121	2	PS50070
Domain	Kringle	PRSS12 MST1L	5.31e-03	17	121	2	PF00051
Domain	SUSHI	CD248 APOH CR1	5.73e-03	56	121	3	PS50923
Domain	CTCK_1	SLIT2 MUC5AC	5.95e-03	18	121	2	PS01185
Domain	Sushi_SCR_CCP_dom	CD248 APOH CR1	6.02e-03	57	121	3	IPR000436
Domain	Ion_trans_dom	CACNA1D KCNA4 KCNH1 KCNH5	6.47e-03	114	121	4	IPR005821
Domain	Ion_trans	CACNA1D KCNA4 KCNH1 KCNH5	6.47e-03	114	121	4	PF00520
Pathway	KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY	TUBB TUBB2B TUBB2A	1.66e-04	17	91	3	M47768
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT	TUBB TUBB2B TUBB2A	1.98e-04	18	91	3	M47753
Pathway	KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT	TUBB TUBB2B TUBB2A	2.34e-04	19	91	3	M47818
Pathway	KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT	TUBB TUBB2B TUBB2A	2.34e-04	19	91	3	M47813
Pathway	KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT	TUBB TUBB2B TUBB2A	2.74e-04	20	91	3	M47890
Pathway	KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS	TUBB TUBB2B TUBB2A	2.74e-04	20	91	3	M47911
Pathway	KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY	TUBB TUBB2B TUBB2A	3.18e-04	21	91	3	M47767
Pathway	KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH	TUBB TUBB2B TUBB2A	3.67e-04	22	91	3	M47903
Pathway	KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION	TUBB TUBB2B TUBB2A	4.20e-04	23	91	3	M47910
Pathway	KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION	TUBB TUBB2B TUBB2A	4.20e-04	23	91	3	M47900
Pathway	REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC	KIF6 KIF26B TMED7 TUBB2B TUBB2A	4.25e-04	98	91	5	MM15352
Pathway	REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC	KIF6 KIF26B TMED7 TUBB2B TUBB2A	4.66e-04	100	91	5	M27650
Pathway	KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT	TUBB TUBB2B TUBB2A	4.77e-04	24	91	3	M47671
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT	TUBB TUBB2B TUBB2A	4.77e-04	24	91	3	M47700
Pathway	REACTOME_KINESINS	KIF6 KIF26B TUBB2B TUBB2A	4.94e-04	57	91	4	MM15714
Pathway	KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT	TUBB TUBB2B TUBB2A	5.40e-04	25	91	3	M47775
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT	TUBB TUBB2B TUBB2A	5.40e-04	25	91	3	M47710
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT	TUBB TUBB2B TUBB2A	6.08e-04	26	91	3	M47672
Pathway	REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION	CHD4 RRAD MEF2A TRIB1	6.40e-04	61	91	4	M152
Pathway	REACTOME_KINESINS	KIF6 KIF26B TUBB2B TUBB2A	6.40e-04	61	91	4	M977
Pathway	KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION	TUBB TUBB2B TUBB2A	7.58e-04	28	91	3	M47898
Pathway	REACTOME_INACTIVATION_OF_CDC42_AND_RAC1	SLIT2 SRGAP1	1.13e-03	8	91	2	M27349
Pathway	KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION	TUBB TUBB2B TUBB2A	1.23e-03	33	91	3	M47901
Pubmed	Evolutionary history of a multigene family: an expressed human beta-tubulin gene and three processed pseudogenes.	TUBB TUBB2B TUBB2A	4.11e-08	3	121	3	6688039
Pubmed	Stabilization of fatty acid synthesis enzyme acetyl-CoA carboxylase 1 suppresses acute myeloid leukemia development.	TRIB2 ACACA TRIB1	1.64e-07	4	121	3	34128473
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	MAP1B TUBB SRPK2 CHD4 MEF2A TUBB2A SORT1 METTL13 UBA7 P4HA1 ANKRD28 SETD7 EIF2AK3 NBR1 TRIB1	3.18e-07	857	121	15	25609649
Pubmed	Mitochondria-cytoskeleton interaction: distribution of β-tubulins in cardiomyocytes and HL-1 cells.	TUBB TUBB2B TUBB2A	4.09e-07	5	121	3	21296049
Pubmed	Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome.	NID2 MAP1B TUBB TUBB2B CHD4 TUBB2A FBN2 EPB41L2	1.06e-06	219	121	8	31353912
Pubmed	CRIPT, a novel postsynaptic protein that binds to the third PDZ domain of PSD-95/SAP90.	TUBB TUBB2A KCNA4	1.42e-06	7	121	3	9581762
Pubmed	Tubulinopathies Overview	TUBB TUBB2B TUBB2A	1.42e-06	7	121	3	27010057
Pubmed	Mutations in the β-tubulin gene TUBB5 cause microcephaly with structural brain abnormalities.	TUBB TUBB2B TUBB2A	2.27e-06	8	121	3	23246003
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	IGSF8 NID2 ACACA CD248 CNTNAP1 TMED7 POMGNT1 CHD4 PRDX2 AGPS CR1 ZFPL1 YARS2 SLIT2 UBA7 P4HA1 CLPTM1 EPB41L2	2.86e-06	1451	121	18	30550785
Pubmed	LDL receptor-related protein as a component of the midkine receptor.	NID2 TUBB2B LRP2	3.40e-06	9	121	3	10772929
Pubmed	Gene-smoking interactions identify several novel blood pressure loci in the Framingham Heart Study.	COLEC10 LRP1B LRP2 TNFRSF19	4.65e-06	32	121	4	25189868
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	USP36 ACACA MAP1B NPEPPS TUBB TUBB2B CHD4 PRDX2 AGPS ECH1 METTL13 ARHGEF40 MICAL2 ANKRD28 PRR14L RIOK2 EPB41L2	4.69e-06	1353	121	17	29467282
Pubmed	A molecular basis for the Ia.2 and Ia.19 antigenic determinants.	HLA-DQA1 HLA-DQA2	1.20e-05	2	121	2	2581258
Pubmed	Over-Expression of βII-Tubulin and Especially Its Localization in Cell Nuclei Correlates with Poorer Outcomes in Colorectal Cancer.	TUBB2B TUBB2A	1.20e-05	2	121	2	30621030
Pubmed	beta2-glycoprotein-I (apolipoprotein H) and beta2-glycoprotein-I-phospholipid complex harbor a recognition site for the endocytic receptor megalin.	APOH LRP2	1.20e-05	2	121	2	9727058
Pubmed	Gastric mucosal hyperplasia via upregulation of gastrin induced by persistent activation of gastric innate immunity in major histocompatibility complex class II deficient mice.	HLA-DQA1 HLA-DQA2	1.20e-05	2	121	2	16322110
Pubmed	Characterization of defective I-A surface expression in a mixed isotype expressing murine B cell lymphoma: continued expression of E alpha d A beta d despite competition from restored A alpha d A beta d pairs.	HLA-DQA1 HLA-DQA2	1.20e-05	2	121	2	1329933
Pubmed	Transient denervation of viable myocardium after myocardial infarction does not alter arrhythmia susceptibility.	SORT1 NGFR	1.20e-05	2	121	2	29101167
Pubmed	Characterization of a phosphoprotein whose mRNA is regulated by the mitogenic pathways in dog thyroid cells.	TRIB2 TRIB1	1.20e-05	2	121	2	9342215
Pubmed	Functional distinction of human EAG1 and EAG2 potassium channels.	KCNH1 KCNH5	1.20e-05	2	121	2	11943152
Pubmed	Tribbles-1 and -2 are tumour suppressors, down-regulated in human acute myeloid leukaemia.	TRIB2 TRIB1	1.20e-05	2	121	2	20005259
Pubmed	Tribbles in normal and malignant haematopoiesis.	TRIB2 TRIB1	1.20e-05	2	121	2	26517933
Pubmed	Presence of an expressed beta-tubulin gene (TUBB) in the HLA class I region may provide the genetic basis for HLA-linked microtubule dysfunction.	TUBB TUBB2A	1.20e-05	2	121	2	8270253
Pubmed	Functional adaptive CD4 Foxp3 T cells develop in MHC class II-deficient mice.	HLA-DQA1 HLA-DQA2	1.20e-05	2	121	2	17142726
Pubmed	Roles for the pro-neurotrophin receptor sortilin in neuronal development, aging and brain injury.	SORT1 NGFR	1.20e-05	2	121	2	17934455
Pubmed	Increasing the survival of dendritic cells in vivo does not replace the requirement for CD4+ T cell help during primary CD8+ T cell responses.	HLA-DQA1 HLA-DQA2	1.20e-05	2	121	2	17947646
Pubmed	MAP1B Interaction with the FW Domain of the Autophagic Receptor Nbr1 Facilitates Its Association to the Microtubule Network.	MAP1B NBR1	1.20e-05	2	121	2	22654911
Pubmed	PCR-RFLP genotyping of murine MHC haplotypes.	HLA-DQA1 HLA-DQA2	1.20e-05	2	121	2	8879564
Pubmed	HLA-DQ6 transgenic mice resistance to experimental autoimmune myasthenia gravis is linked to reduced acetylcholine receptor-specific IFN-gamma, IL-2 and IL-10 production.	HLA-DQA1 HLA-DQA2	1.20e-05	2	121	2	11712854
Pubmed	Identification of MKRN1 as a second E3 ligase for Eag1 potassium channels reveals regulation via differential degradation.	MKRN1 KCNH1	1.20e-05	2	121	2	33647316
Pubmed	Structure and expression of HLA-DQ alpha and -DX alpha genes: interallelic alternate splicing of the HLA-DQ alpha gene and functional splicing of the HLA-DQ alpha gene using a retroviral vector.	HLA-DQA1 HLA-DQA2	1.20e-05	2	121	2	3610256
Pubmed	Development of a major histocompatibility complex class II conditional knockout mouse to study cell-specific and time-dependent adaptive immune responses in peripheral nerves.	HLA-DQA1 HLA-DQA2	1.20e-05	2	121	2	38922958
Pubmed	The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders.	HLA-DQA1 HLA-DQA2	1.20e-05	2	121	2	8543793
Pubmed	Major histocompatibility complex class II expression by intrinsic renal cells is required for crescentic glomerulonephritis.	HLA-DQA1 HLA-DQA2	1.20e-05	2	121	2	9687536
Pubmed	Neuronal death in the dorsal root ganglion after sciatic nerve injury does not depend on sortilin.	SORT1 NGFR	1.20e-05	2	121	2	26812033
Pubmed	Roles of surface residues of intracellular domains of heag potassium channels.	KCNH1 KCNH5	1.20e-05	2	121	2	19172261
Pubmed	Targeted disruption of the MHC class II Aa gene in C57BL/6 mice.	HLA-DQA1 HLA-DQA2	1.20e-05	2	121	2	8398989
Pubmed	Impaired ability of MHC class II-/- dendritic cells to provide tumor protection is rescued by CD40 ligation.	HLA-DQA1 HLA-DQA2	1.20e-05	2	121	2	10384102
Pubmed	Regions of allelic hypervariability in the murine A alpha immune response gene.	HLA-DQA1 HLA-DQA2	1.20e-05	2	121	2	6309407
Pubmed	Intermediate steps in positive selection: differentiation of CD4+8int TCRint thymocytes into CD4-8+TCRhi thymocytes.	HLA-DQA1 HLA-DQA2	1.20e-05	2	121	2	7722444
Pubmed	Ag-presenting CpG-activated pDCs prime Th17 cells that induce tumor regression.	HLA-DQA1 HLA-DQA2	1.20e-05	2	121	2	25252912
Pubmed	A comparative approach linking molecular dynamics of altered peptide ligands and MHC with in vivo immune responses.	HLA-DQA1 HLA-DQA2	1.20e-05	2	121	2	20657836
Pubmed	Ancient roots for polymorphism at the HLA-DQ alpha locus in primates.	HLA-DQA1 HLA-DQA2	1.20e-05	2	121	2	2513578
Pubmed	CD8+ T cells are capable of rejecting pancreatic islet xenografts.	HLA-DQA1 HLA-DQA2	1.20e-05	2	121	2	11014643
Pubmed	Survival of mature CD4 T lymphocytes is dependent on major histocompatibility complex class II-expressing dendritic cells.	HLA-DQA1 HLA-DQA2	1.20e-05	2	121	2	9334361
Pubmed	CD1d-restricted NKT cells contribute to malarial splenomegaly and enhance parasite-specific antibody responses.	HLA-DQA1 HLA-DQA2	1.20e-05	2	121	2	12938235
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	IGSF8 MAP1B CNTNAP1 TMED7 POMGNT1 PRDX2 CHORDC1 LRP1B SORT1 FBN2 IGFBP7 P4HA1 MICAL2 CLPTM1 EIF2AK3	1.92e-05	1201	121	15	35696571
Pubmed	MEKK4 Signaling Regulates Sensory Cell Development and Function in the Mouse Inner Ear.	TUBB2B TUBB2A NGFR	2.23e-05	16	121	3	26818521
Pubmed	Proteome-wide analysis of USP14 substrates revealed its role in hepatosteatosis via stabilization of FASN.	MAP1B NPEPPS OBSCN TUBB2B TUBB2A PHF14 HDGFL2 EPB41L2	2.34e-05	334	121	8	30425250
Pubmed	Proteomic analysis identifies dysfunction in cellular transport, energy, and protein metabolism in different brain regions of atypical frontotemporal lobar degeneration.	IGSF8 CNTNAP1 TUBB PRDX2 TUBB2A	2.34e-05	97	121	5	22360420
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	ACACA SELENBP1 NPEPPS TUBB TMED7 CHD4 PRDX2 ECH1 TUBB2A ADH5 KMT2A ZNF749	2.61e-05	807	121	12	30575818
Pubmed	Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways.	NID2 MAP1B ZSWIM5 TUBB OBSCN CHD4 ECH1 TUBB2A SORT1 MUC5AC	2.94e-05	564	121	10	21565611
Pubmed	New genetic associations detected in a host response study to hepatitis B vaccine.	FLT4 HLA-DQA2 COLEC10 TNFRSF10D PRDX2 APOH CR1 NFE2L3 SRGAP1 JAG1 NGFR TNFRSF19	3.20e-05	824	121	12	20237496
Pubmed	MHC class II-independent CD25+ CD4+ CD8alpha beta+ alpha beta T cells attenuate CD4+ T cell-induced transfer colitis.	HLA-DQA1 HLA-DQA2	3.59e-05	3	121	2	14991600
Pubmed	T cell-dependence of Lassa fever pathogenesis.	HLA-DQA1 HLA-DQA2	3.59e-05	3	121	2	20360949
Pubmed	Pseudokinases: a tribble-edged sword.	TRIB2 TRIB1	3.59e-05	3	121	2	31621188
Pubmed	Aldolase-tubulin interactions: removal of tubulin C-terminals impairs interactions.	TUBB TUBB2A	3.59e-05	3	121	2	8103323
Pubmed	Activated mouse T-cells synthesize MHC class II, process, and present morbillivirus nucleocapsid protein to primed T-cells.	HLA-DQA1 HLA-DQA2	3.59e-05	3	121	2	16083868
Pubmed	Synaptotagmin IX, a possible linker between the perinuclear endocytic recycling compartment and the microtubules.	TUBB TUBB2A	3.59e-05	3	121	2	12966166
Pubmed	Unlike Its Paralog LEDGF/p75, HRP-2 Is Dispensable for MLL-R Leukemogenesis but Important for Leukemic Cell Survival.	KMT2A HDGFL2	3.59e-05	3	121	2	33477970
Pubmed	A novel inducible von Willebrand Factor Cre recombinase mouse strain to study microvascular endothelial cell-specific biological processes in vivo.	HLA-DQA1 HLA-DQA2	3.59e-05	3	121	2	38554988
Pubmed	Dissecting MHC class II export, B cell maturation, and DM stability defects in invariant chain mutant mice.	HLA-DQA1 HLA-DQA2	3.59e-05	3	121	2	15322189
Pubmed	The murine Ia alpha chains, E alpha and A alpha, show a surprising degree of sequence homology.	HLA-DQA1 HLA-DQA2	3.59e-05	3	121	2	6300851
Pubmed	Novel pathogenic variants and multiple molecular diagnoses in neurodevelopmental disorders.	CHD4 KMT5B	3.59e-05	3	121	2	31238879
Pubmed	Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo.	HLA-DQA1 HLA-DQA2	3.59e-05	3	121	2	9053454
Pubmed	Tribbles role in reproduction.	TRIB2 TRIB1	3.59e-05	3	121	2	26517934
Pubmed	Tribbles in inflammation.	TRIB2 TRIB1	3.59e-05	3	121	2	26517925
Pubmed	Tribbles and arthritis: what are the links?	TRIB2 TRIB1	3.59e-05	3	121	2	26517922
Pubmed	Tribbles pseudokinases: novel targets for chemical biology and drug discovery?	TRIB2 TRIB1	3.59e-05	3	121	2	26517930
Pubmed	Farnesyl pyrophosphate promotes and is essential for the binding of RACK1 with beta-tubulin.	TUBB TUBB2A	3.59e-05	3	121	2	12884273
Pubmed	NRH2 is a trafficking switch to regulate sortilin localization and permit proneurotrophin-induced cell death.	SORT1 NGFR	3.59e-05	3	121	2	19407813
Pubmed	HLA class II nucleotide sequences, 1992.	HLA-DQA1 HLA-DQA2	3.59e-05	3	121	2	1362295
Pubmed	Inverse and correlative relationships between TRIBBLES genes indicate non-redundant functions during normal and malignant hemopoiesis.	TRIB2 TRIB1	3.59e-05	3	121	2	30031847
Pubmed	Circulating, soluble forms of major histocompatibility complex antigens are not exosome-associated.	HLA-DQA1 HLA-DQA2	3.59e-05	3	121	2	17072917
Pubmed	Interdependency of MHC class II/self-peptide and CD1d/self-glycolipid presentation by TNF-matured dendritic cells for protection from autoimmunity.	HLA-DQA1 HLA-DQA2	3.59e-05	3	121	2	17404272
Pubmed	ProNGF induces TNFalpha-dependent death of retinal ganglion cells through a p75NTR non-cell-autonomous signaling pathway.	SORT1 NGFR	3.59e-05	3	121	2	20133718
Pubmed	The loop diuretic bumetanide blocks posttraumatic p75NTR upregulation and rescues injured neurons.	SORT1 NGFR	3.59e-05	3	121	2	22302815
Pubmed	Mutations of the SLIT2-ROBO2 pathway genes SLIT2 and SRGAP1 confer risk for congenital anomalies of the kidney and urinary tract.	SLIT2 SRGAP1	3.59e-05	3	121	2	26026792
Pubmed	The class II molecules of the human and murine major histocompatibility complex.	HLA-DQA1 HLA-DQA2	3.59e-05	3	121	2	6198089
Pubmed	Upregulation of Tribbles decreases body weight and increases sleep duration.	TRIB2 TRIB1	3.59e-05	3	121	2	37083954
Pubmed	Molecular dissection of the myelin-associated glycoprotein receptor complex reveals cell type-specific mechanisms for neurite outgrowth inhibition.	NGFR TNFRSF19	3.59e-05	3	121	2	17470639
Pubmed	Plasmacytoid dendritic cells induce tolerance predominantly by cargoing antigen to lymph nodes.	HLA-DQA1 HLA-DQA2	3.59e-05	3	121	2	27592607
Pubmed	The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique.	HLA-DQA1 HLA-DQA2	3.59e-05	3	121	2	2882518
Pubmed	Perinuclear localization of huntingtin as a consequence of its binding to microtubules through an interaction with beta-tubulin: relevance to Huntington's disease.	TUBB TUBB2A	3.59e-05	3	121	2	11870213
Pubmed	Revisiting the specificity of the MHC class II transactivator CIITA in vivo.	HLA-DQA1 HLA-DQA2	3.59e-05	3	121	2	16703565
Pubmed	Crystal structure of I-Ak in complex with a dominant epitope of lysozyme.	HLA-DQA1 HLA-DQA2	3.59e-05	3	121	2	9529148
Pubmed	Tribbles: novel regulators of cell function; evolutionary aspects.	TRIB2 TRIB1	3.59e-05	3	121	2	16715410
Pubmed	Low-Level MHC Class II Expression Leads to Suboptimal Th Cell Response, Increased Autoaggression, and Heightened Cytokine Inducibility.	HLA-DQA1 HLA-DQA2	3.59e-05	3	121	2	28108557
Pubmed	Alternate interactions define the binding of peptides to the MHC molecule IA(b).	HLA-DQA1 HLA-DQA2	3.59e-05	3	121	2	12084926
Pubmed	Tribbles in acute leukemia.	TRIB2 TRIB1	3.59e-05	3	121	2	23550039
Pubmed	Potent inhibition of L-type Ca2+ currents by a Rad variant associated with congestive heart failure.	CACNA1D RRAD	3.59e-05	3	121	2	23973784
Pubmed	Finding genes and variants for lipid levels after genome-wide association analysis.	SORT1 TRIB1	3.59e-05	3	121	2	22418572
Pubmed	Cloning, expression, and properties of the microtubule-stabilizing protein STOP.	TUBB TUBB2A	3.59e-05	3	121	2	8700896
Pubmed	Implications of aging and self-tolerance on the generation of immune and antitumor immune responses.	HLA-DQA1 HLA-DQA2	3.59e-05	3	121	2	18593945
Pubmed	β-Tubulin mutations that cause severe neuropathies disrupt axonal transport.	TUBB TUBB2A	3.59e-05	3	121	2	23503589
Pubmed	Neurotrophin Receptors TrkA, p75NTR, and Sortilin Are Increased and Targetable in Thyroid Cancer.	SORT1 NGFR	3.59e-05	3	121	2	29037860
Pubmed	Valproic acid upregulates the expression of the p75NTR/sortilin receptor complex to induce neuronal apoptosis.	SORT1 NGFR	3.59e-05	3	121	2	32712736
Pubmed	Indirect presentation in the thymus limits naive and regulatory T-cell differentiation by promoting deletion of self-reactive thymocytes.	HLA-DQA1 HLA-DQA2	3.59e-05	3	121	2	29411880
Pubmed	A triad of molecular regions contribute to the formation of two distinct MHC class II conformers.	HLA-DQA1 HLA-DQA2	3.59e-05	3	121	2	27148821
Pubmed	Rapid Death of Follicular B Cells and Burkitt Lymphoma Cells Effectuated by Xbp1s.	HLA-DQA1 HLA-DQA2	3.59e-05	3	121	2	32376649
GeneFamily	Tubulins	TUBB TUBB2B TUBB2A	2.17e-04	26	82	3	778
GeneFamily	CD molecules\|Tumor necrosis factor receptor superfamily\|Death inducing signaling complex	TNFRSF10D NGFR TNFRSF19	3.02e-04	29	82	3	782
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	KMT5B KMT2A SETD7	4.86e-04	34	82	3	487
GeneFamily	Potassium voltage-gated channels	KCNA4 KCNH1 KCNH5	7.87e-04	40	82	3	274
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	FLT4 ADAMTSL1 OBSCN IGFBP7 KAZALD1	8.27e-04	161	82	5	593
GeneFamily	Low density lipoprotein receptors	LRP1B LRP2	1.53e-03	13	82	2	634
GeneFamily	ATPase phospholipid transporting	ATP8B4 ATP8B2	2.05e-03	15	82	2	1210
Coexpression	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN	NID2 MAP1B PRSS12 TUBB TNFRSF10D AGPS SYDE1 SLIT2 ARHGEF40 IGFBP7 JAG1 ANKRD28 EPB41L2	2.28e-07	465	120	13	M9192
Coexpression	SANSOM_APC_TARGETS_UP	TUBB2B PRDX2 TUBB2A RNASE4 TNFRSF19 TRIB1	3.32e-05	132	120	6	M1428
Coexpression	SANSOM_APC_TARGETS_UP	TUBB2B PRDX2 TUBB2A RNASE4 TNFRSF19 TRIB1	3.62e-05	134	120	6	MM624
Coexpression	GSE27786_CD4_VS_CD8_TCELL_DN	ATP8B4 ACACA PRSS12 TUBB METTL13 IGFBP7 BAIAP3	3.77e-05	199	120	7	M4821
Coexpression	GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN	TUBB TUBB2B COLQ MEF2A TUBB2A ARHGAP20 EPB41L2	3.77e-05	199	120	7	M9178
Coexpression	MCBRYAN_PUBERTAL_BREAST_4_5WK_DN	NID2 ACACA HLA-DQA1 HLA-DQA2 ECH1 JAG1 EPB41L2	4.84e-05	207	120	7	MM988
Coexpression	MENON_FETAL_KIDNEY_2_NEPHRON_PROGENITOR_CELLS	TRIB2 TUBB2B JAG1 MST1L	4.92e-05	44	120	4	M39252
Coexpression	CHICAS_RB1_TARGETS_CONFLUENT	MAP1B PRSS12 CNTNAP1 TUBB TUBB2B TUBB2A NFE2L3 FBN2 TNFRSF19 IL17RD EPB41L2	6.10e-05	567	120	11	M2129
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	TRIB2 MAP1B CD248 TUBB2B COLEC10 NFE2L3 SLIT2 FBN2 IGFBP7 EPB41L2	1.98e-10	200	121	10	d2fcd3bd7c3223875f027eeb48ff621192a5f242
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGSF8 ADAMTSL1 MAP1B TUBB2B KCNA4 LRRC53 SRPK3 KCNH5 GP2	2.66e-09	190	121	9	40d8b3403f4e38436b961cd3a2e69826cbae3042
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine-Neuroendocrine_L.0.7.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGSF8 ADAMTSL1 MAP1B TUBB2B KCNA4 LRRC53 SRPK3 KCNH5 GP2	2.66e-09	190	121	9	f6cbf6d292f488ada5f7581e1dceba6198b933d1
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGSF8 ADAMTSL1 MAP1B TUBB2B KCNA4 LRRC53 SRPK3 KCNH5 GP2	2.66e-09	190	121	9	a9a705455019e28d655636de73b07540798f82e6
ToppCell	background-Hepatic_Stellate_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	NID2 ADAMTSL1 MAP1B COLEC10 SLIT2 SSC5D IGFBP7 JAG1 NGFR	3.81e-09	198	121	9	bd11b0e9e80449aab979a02c1023e0638c431c7c
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRIB2 MAP1B CD248 COLEC10 SLIT2 FBN2 IGFBP7 WDR17	3.91e-08	183	121	8	8a799807fbf24456a9811e0c64068187940a2f71
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TRIB2 MAP1B TUBB2B PRDX2 TUBB2A SRGAP1 PHF14 HDGFL2	3.91e-08	183	121	8	af14da45267261e775dd6dab7a4c359b181e46f1
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Pericyte\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	TRIB2 MAP1B CD248 TUBB2B COLEC10 SLIT2 FBN2 IGFBP7	7.76e-08	200	121	8	4e1e19214aeebbdca004de7faaf4cc9d18498591
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	TRIB2 MAP1B CD248 TUBB2B COLEC10 SLIT2 IGFBP7 EPB41L2	7.76e-08	200	121	8	786f1ae53e60b5ffbf4bfd393d10b802478148b3
ToppCell	LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_only / Treatment groups by lineage, cell group, cell type	TRIB2 MAP1B CD248 COLEC10 SLIT2 ARHGEF40 IGFBP7 WDR17	7.76e-08	200	121	8	69edc375d85689300d1dbc1217fedc40063ecdcb
ToppCell	NS-moderate-d_07-13-Lymphoid-NK\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	NID2 MAP1B TUBB2B ATP8B2 SYDE1 C3orf70 NGFR	5.19e-07	175	121	7	f6cd24d22f62469319f9d244e3e5de527d3d4d94
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D231\|Adult / Lineage, Cell type, age group and donor	CACNA1D ADAMTSL1 CD248 HOXA3 SLIT2 SSC5D IGFBP7	7.54e-07	185	121	7	fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804
ToppCell	droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CACNA1D SELENBP1 COLQ SLIT2 RNASE4 IGFBP7 TNFRSF19	9.34e-07	191	121	7	36467322096bc766cd777dae3bfb4e65511e492c
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAP1B RRAD IGFBP7 MICAL2 JAG1 NGFR WDR17	9.34e-07	191	121	7	9431ffd6b758f756609d9057de2023596e22b5d4
ToppCell	droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CACNA1D SELENBP1 COLQ SLIT2 RNASE4 IGFBP7 TNFRSF19	9.34e-07	191	121	7	94795daf05061baa3b72a1b01c9e940af86de044
ToppCell	facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NID2 ADAMTSL1 CD248 SLIT2 SSC5D FBN2 ARHGAP20	9.67e-07	192	121	7	8937a59f6bbe07f671bdabbd3707dc9c17a14cd9
ToppCell	facs-Pancreas-Exocrine-3m-Mesenchymal\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NID2 ADAMTSL1 CD248 SLIT2 SSC5D FBN2 ARHGAP20	9.67e-07	192	121	7	e4a7f2673f801b008ca67291db2fb2b9fd2955b8
ToppCell	facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NID2 ADAMTSL1 CD248 SLIT2 SSC5D FBN2 ARHGAP20	9.67e-07	192	121	7	ac1477433704573f95111eee6263b93668d2845e
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NID2 ADAMTSL1 CD248 SLIT2 SSC5D IGFBP7 IL17RD	9.67e-07	192	121	7	e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81
ToppCell	wk_08-11-Mesenchymal-Myofibro_&_SMC-MYL4+_SMC\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	MAP1B KIF26B TUBB2B RRAD SSC5D C3orf70 TNFRSF19	1.07e-06	195	121	7	dba2a87efd7e067c094c4b367feb4138cab62735
ToppCell	COVID-19-kidney-Fibroblast-2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NID2 ADAMTSL1 TRIB2 MAP1B HOXA3 IGFBP7 EPB41L2	1.07e-06	195	121	7	3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2
ToppCell	Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MAP1B CNTNAP1 IGFBP7 C3orf70 NGFR TNFRSF19 IL17RD	1.15e-06	197	121	7	6806ec223e542f0475303698eb78c1cc527f5c6b
ToppCell	3'-Adult-LymphNode-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAP1B CD248 LRP1B SLIT2 RNASE4 IGFBP7 NGFR	1.19e-06	198	121	7	abac765c4f6864bdb1700bc546c3b9771edc25c3
ToppCell	Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-Immature_CPNs\|3_mon / Sample Type, Dataset, Time_group, and Cell type.	MAP1B PRSS12 TUBB TUBB2B PRDX2 TUBB2A SRGAP1	1.19e-06	198	121	7	32d58379a89be19b6b1a494bf033416546771c19
ToppCell	3'-Adult-LargeIntestine-Neuronal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAP1B TUBB2B TMEM71 IGFBP7 NGFR TNFRSF19 GJC3	1.19e-06	198	121	7	2488ea95003f218afb25ecc873805b825e6cc409
ToppCell	Fibroblasts-HLA-DRA_high_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	NID2 SELENBP1 CD248 SLIT2 SSC5D IGFBP7 SRGAP1	1.19e-06	198	121	7	e8c0fbf306fae13e97caa294d7c99a564bd97130
ToppCell	3'-Adult-LargeIntestine-Neuronal-Glial_mature-Adult_Glia\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAP1B TUBB2B TMEM71 IGFBP7 NGFR TNFRSF19 GJC3	1.19e-06	198	121	7	991db02a76f7506848827601e927cf997cb520d3
ToppCell	3'-Adult-LymphNode-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAP1B CD248 LRP1B SLIT2 RNASE4 IGFBP7 NGFR	1.19e-06	198	121	7	ff57addcbdd53e5d2d0c80ec76b5eab3b3a67ca2
ToppCell	3'-Adult-LargeIntestine-Neuronal-Glial_mature\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAP1B TUBB2B TMEM71 IGFBP7 NGFR TNFRSF19 GJC3	1.19e-06	198	121	7	98ab27335d126fa7817a46953948e524d91248f8
ToppCell	3'-Adult-LymphNode-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAP1B CD248 LRP1B SLIT2 RNASE4 IGFBP7 NGFR	1.19e-06	198	121	7	698166b4ca173176ed563af6a1efc8c7d0a18e0b
ToppCell	Control_saline\|World / Treatment groups by lineage, cell group, cell type	NID2 FLT4 TUBB COLEC10 MEF2A FBN2 JAG1	1.23e-06	199	121	7	11c9c1779caceb725ecccf3f23b7d4e6dbd1af64
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	CACNA1D KIF26B SLIT2 IGFBP7 SRGAP1 ARHGAP20 EPB41L2	1.27e-06	200	121	7	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	TRIB2 MAP1B CD248 TUBB2B SLIT2 FBN2 IGFBP7	1.27e-06	200	121	7	b5b5a32925f225610fe25a021a742d6397162863
ToppCell	LPS_only-Mesenchymal_myocytic-Pericyte\|LPS_only / Treatment groups by lineage, cell group, cell type	MAP1B CD248 SLIT2 ARHGEF40 FBN2 IGFBP7 JAG1	1.27e-06	200	121	7	8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	CACNA1D NID2 ADH5 SLIT2 IGFBP7 SRGAP1 ARHGAP20	1.27e-06	200	121	7	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2\|Control_saline / Treatment groups by lineage, cell group, cell type	TRIB2 CD248 NFE2L3 SLIT2 FBN2 IGFBP7 EPB41L2	1.27e-06	200	121	7	bc8949eb34482aca166c4602ff6ab876cb4c2c3c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CD248 TEX14 SSC5D MICAL2 ZNF543 EPB41L2	6.02e-06	165	121	6	e2aebb2fe197151e019371b8960f76f0c2386f08
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CD248 TEX14 SSC5D MICAL2 ZNF543 EPB41L2	6.02e-06	165	121	6	b087771499aeb31cc4a338d2d0a9392a4ec1ac45
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CD248 TEX14 SSC5D MICAL2 ZNF543 EPB41L2	6.02e-06	165	121	6	d8f8b088fd28a6b9dbd6b51bcaee42000e963321
ToppCell	droplet-Marrow-nan-24m-Hematologic-erythroid_progenitor\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRIB2 HLA-DQA1 TEX14 TNFRSF19 SRPK3 BCAR3	7.64e-06	172	121	6	910ec7794ea4000db4ef1e2c34e08dbc0243df2c
ToppCell	droplet-Marrow-BM-1m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USP36 CNTNAP1 TUBB2B ATP8B2 KAZALD1 BCAR3	8.71e-06	176	121	6	2e9073166da4d9fae70ba4f3fdcad35523caf7cd
ToppCell	356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	CACNA1D NID2 MAP1B KIF26B PPM1E SLIT2	9.00e-06	177	121	6	cdfd2f0ee2f692271b1525e414b0f645cdadb1f6
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTSL1 SLIT2 KCNH1 ARHGAP20 EPB41L2 KCNH5	9.00e-06	177	121	6	9ec7f1e64312d26d434b3312b58386715dbad644
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTSL1 SLIT2 KCNH1 ARHGAP20 EPB41L2 KCNH5	9.00e-06	177	121	6	016277dfd59b1793fddaaadc2b3f41622d76ce3a
ToppCell	356C-Fibroblasts-Fibroblast-C_(Myofibroblast)\|356C / Donor, Lineage, Cell class and subclass (all cells)	CACNA1D NID2 MAP1B KIF26B PPM1E SLIT2	9.00e-06	177	121	6	db222faaecbe5600da39277243c4e7e764eb63c9
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CD248 COLEC10 TEX14 SYDE1 IGFBP7 JAG1	9.29e-06	178	121	6	e5e4742e35c3d90f82b830d77bdbdc45828c7deb
ToppCell	mild_COVID-19_(asymptomatic)-cDC\|World / disease group, cell group and cell class (v2)	HLA-DQA1 HLA-DQA2 MEF2A IGFBP7 BCAR3 EPB41L2	9.90e-06	180	121	6	68d1c867734fb2977b01ac686b20bf602f9a6b72
ToppCell	COPD-Lymphoid-B_Plasma\|Lymphoid / Disease state, Lineage and Cell class	TEX14 RRAD MEF2A ANKRD28 EIF2AK3 TRIB1	1.05e-05	182	121	6	19db653fe04c5e2957eea1f4893b1c1fca4ddcbd
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAP1B RRAD IGFBP7 MICAL2 JAG1 KAZALD1	1.09e-05	183	121	6	b4f29dd3994009bb5eb769d36d95886664e7f87d
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF26B OBSCN LRP1B FBN2 KCNA4 LRP2	1.12e-05	184	121	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	normal_Lung-Fibroblasts-Myofibroblasts\|normal_Lung / Location, Cell class and cell subclass	MAP1B CD248 KIF26B TUBB2B SSC5D TNFRSF19	1.12e-05	184	121	6	0b336489c10e8c3c957795dd845454f03404382b
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF26B OBSCN LRP1B FBN2 KCNA4 LRP2	1.12e-05	184	121	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF26B OBSCN LRP1B FBN2 KCNA4 LRP2	1.12e-05	184	121	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	5'-Adult-LargeIntestine-Neuronal-Glial_mature\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TUBB2B TMEM71 IGFBP7 NGFR TNFRSF19 EPB41L2	1.16e-05	185	121	6	f607b6ee579562e2f92103fa5c7053df0170a229
ToppCell	5'-Adult-LargeIntestine-Neuronal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TUBB2B TMEM71 IGFBP7 NGFR TNFRSF19 EPB41L2	1.16e-05	185	121	6	317f2c854f00aa5957319b818c85eeed7d72ec7f
ToppCell	5'-Adult-LargeIntestine-Neuronal-Glial_mature-Adult_Glia\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TUBB2B TMEM71 IGFBP7 NGFR TNFRSF19 EPB41L2	1.16e-05	185	121	6	7bb8fdfe04f85d25056380ec58222366de323a21
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NID2 MAP1B COLEC10 IGFBP7 KCNH1 EPB41L2	1.19e-05	186	121	6	0c477016c1b539b3086a8066c3c6443f08c222a3
ToppCell	droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD248 CNTNAP1 COLEC10 SYDE1 NGFR IL17RD	1.23e-05	187	121	6	b6ecf55014f246461bf1ca12f24cb4d046661fa4
ToppCell	droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD248 CNTNAP1 COLEC10 SYDE1 NGFR IL17RD	1.23e-05	187	121	6	9fb15f24b9b364b0c4704ec98aec236eaec5411c
ToppCell	Smart-seq2-blood_(Smart-seq2)-hematologic-erythrocytic-erythrocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SELENBP1 MKRN1 TUBB2B PRDX2 TUBB2A MICAL2	1.23e-05	187	121	6	c4ba9dfedbcf0357a8627af03f4fe1770e985a03
ToppCell	Smart-seq2-blood_(Smart-seq2)-hematologic-erythrocytic\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SELENBP1 MKRN1 TUBB2B PRDX2 TUBB2A MICAL2	1.23e-05	187	121	6	13023661c26aaf9e42262a4ff91f2fb26e8a3eaf
ToppCell	droplet-Liver-HEPATOCYTES-1m-Mesenchymal\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD248 CNTNAP1 COLEC10 SYDE1 NGFR IL17RD	1.23e-05	187	121	6	e6afbaed352310a1cb49571a2aae18be1f533c9a
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAP1B CD248 OBSCN RRAD SYDE1 IGFBP7	1.27e-05	188	121	6	ccddc08121caff958a2b6f9e278a018858af6b4d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CD248 CNTNAP1 SSC5D MICAL2 NGFR EPB41L2	1.27e-05	188	121	6	32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	KIF26B RRAD SSC5D IGFBP7 C3orf70 TNFRSF19	1.27e-05	188	121	6	c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6\|TCGA-Breast / Sample_Type by Project: Shred V9	ATP8B2 SLIT2 SSC5D ARHGEF40 IGFBP7 NGFR	1.27e-05	188	121	6	c90669b51e1902fe7726555290c91c92a911df83
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTSL1 MAP1B IGFBP7 MICAL2 SRGAP1 EPB41L2	1.35e-05	190	121	6	1121eb607a984c59fbffe7220837fc178745aa55
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTSL1 MAP1B IGFBP7 MICAL2 SRGAP1 EPB41L2	1.35e-05	190	121	6	048b581e3f7ea9fc2f87c0532974bba85c7292c2
ToppCell	droplet-Lung-immune-endo-depleted-3m-Mesenchymal-fibroblast_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SELENBP1 COLQ SLIT2 RNASE4 IGFBP7 TNFRSF19	1.39e-05	191	121	6	a261f0738d974784bbdd60f23092bfbcca464459
ToppCell	Control-Stromal_mesenchymal\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1D PRSS12 RRAD SSC5D TNFRSF19 ARHGAP20	1.39e-05	191	121	6	14057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCell	droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Alveolar_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SELENBP1 COLQ SLIT2 RNASE4 IGFBP7 TNFRSF19	1.39e-05	191	121	6	6594398cc8151c73696391a43ac110c10283dab1
ToppCell	facs-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CACNA1D SELENBP1 COLQ SLIT2 RNASE4 TNFRSF19	1.39e-05	191	121	6	d4f535b06ad483448ab692e9900c872c78cbed60
ToppCell	3'-Child09-12-SmallIntestine-Neuronal-Glial_mature\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAP1B TUBB2B TMEM71 IGFBP7 NGFR EPB41L2	1.43e-05	192	121	6	ac507fd7cf3b3e521a15ef03bb4e81eb23807985
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3\|lymph-node_spleen / Manually curated celltypes from each tissue	ATP8B4 RRAD HOXA3 IGFBP7 JAG1 ANKRD28	1.43e-05	192	121	6	e16035b3328f9b1b2e28d234c62ba88387540550
ToppCell	3'-Child09-12-SmallIntestine-Neuronal\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAP1B TUBB2B TMEM71 IGFBP7 NGFR EPB41L2	1.43e-05	192	121	6	24f40dadec04f4f99c31000fa9f09d07148fa190
ToppCell	3'-Child09-12-SmallIntestine-Neuronal-Glial_mature-Adult_Glia\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAP1B TUBB2B TMEM71 IGFBP7 NGFR EPB41L2	1.43e-05	192	121	6	71e04e197825856c6d4278fc76c58ab17ffa2387
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	NID2 PRSS12 IGFBP7 NGFR TNFRSF19 GJC3	1.47e-05	193	121	6	e1de67ddada87229f5db0ec193a6da8745a86a64
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal-choroid_plexus/mesenchymal-like_cells\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	NID2 PRSS12 IGFBP7 NGFR TNFRSF19 GJC3	1.47e-05	193	121	6	b6f5a85210e60798205eaf5884cdb540f549d08a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NID2 MAP1B MICAL2 NGFR ARHGAP20 EPB41L2	1.51e-05	194	121	6	c49f72441b3557e2c3a9c4239e68c0cf0652814b
ToppCell	3'-Child04-06-SmallIntestine-Neuronal\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAP1B TUBB2B TMEM71 IGFBP7 NGFR EPB41L2	1.56e-05	195	121	6	8d286622f86c844d1b06a106ee4a3f813eba05bb
ToppCell	3'-Child04-06-SmallIntestine-Neuronal-Glial_mature\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAP1B TUBB2B TMEM71 IGFBP7 NGFR EPB41L2	1.56e-05	195	121	6	4193e58788e90c3d1049ef5cf9800a8c4d8ac354
ToppCell	10x5'\|World / Manually curated celltypes from each tissue	PIM2 HLA-DQA1 HLA-DQA2 TUBB CHORDC1 EIF2AK3	1.56e-05	195	121	6	de28b998793271c4f69ce9e183c3e62d809e9cc8
ToppCell	3'-Child04-06-SmallIntestine-Neuronal-Glial_mature-Adult_Glia\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAP1B TUBB2B TMEM71 IGFBP7 NGFR EPB41L2	1.56e-05	195	121	6	359b9d791e26844675c3c60cf69d8ab69c2cf400
ToppCell	LPS_only-Unknown-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PPM1E COLEC10 HOXA3 WDR17 KCNH5	1.57e-05	115	121	5	ad5298c2ad8bf94fa13c2e50b0799e929473ef59
ToppCell	LPS_only-Unknown\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PPM1E COLEC10 HOXA3 WDR17 KCNH5	1.57e-05	115	121	5	7a733f6987b40ec497a03734b79ed5355ad3a2fc
ToppCell	LPS_only-Unknown-Endothelial-Pericyte_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PPM1E COLEC10 HOXA3 WDR17 KCNH5	1.57e-05	115	121	5	c67145d3cd9243994a141749b426ff2a6dcc8d93
ToppCell	3'-Pediatric_IBD-SmallIntestine-Mesenchymal-Pericytes\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NID2 MAP1B RRAD SYDE1 IGFBP7 JAG1	1.65e-05	197	121	6	4d63a274828ebb951db78421c2823453d862cd49
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-MYL4+_SMC\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	MAP1B KIF26B TUBB2B SSC5D C3orf70 TNFRSF19	1.65e-05	197	121	6	4797f414330316e2ac2cf7cd2570d991877d7a38
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MAP1B TUBB2B IGFBP7 C3orf70 NGFR EPB41L2	1.65e-05	197	121	6	b2f4d7c301c0b24003374923b31d6d058e40b213
ToppCell	3'-Pediatric_IBD-SmallIntestine-Mesenchymal-Pericytes-Pericyte\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NID2 MAP1B CD248 SYDE1 IGFBP7 JAG1	1.65e-05	197	121	6	452be45f4aac8459dd860493171f5f715368d663
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD248 TUBB2B SYDE1 HOXA3 SLIT2 ARHGAP20	1.70e-05	198	121	6	5cfd1c030c0940136a397b5a4b5d6ecbaecf72eb
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ATP8B4 HLA-DQA1 HLA-DQA2 LRP1B IGFBP7 EPB41L2	1.70e-05	198	121	6	898ef4f02443780f9b1fc08b73a165fda0ca5cde
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NID2 SLIT2 SSC5D JAG1 NGFR KAZALD1	1.70e-05	198	121	6	9541d68a1a6247dbd7161a62644eea6527c2c8ff
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ATP8B4 HLA-DQA1 HLA-DQA2 LRP1B IGFBP7 EPB41L2	1.70e-05	198	121	6	d0371e2ca9e25727b35985940f6228f9d8e49727
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD248 TUBB2B SYDE1 HOXA3 SLIT2 ARHGAP20	1.70e-05	198	121	6	ff6d9455ebfe965cc6f48197172c0ebd3bddde81
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-conventional_dendritic_cell\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ATP8B4 HLA-DQA1 HLA-DQA2 LRP1B IGFBP7 EPB41L2	1.70e-05	198	121	6	08ad0bece508bb4f9cc126d94839b5c89ce21ba8
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD248 TUBB2B SYDE1 HOXA3 SLIT2 ARHGAP20	1.70e-05	198	121	6	5375a2895cf995f0db4a61861093f01794707901
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD248 TUBB2B SYDE1 HOXA3 SLIT2 ARHGAP20	1.70e-05	198	121	6	35edf6d5bedc2181fbdd56f43e458bc39f4eca16
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NID2 MAP1B TUBB NGFR ARHGAP20 EPB41L2	1.70e-05	198	121	6	d9ffc6589ed510ffa60c591f2a0fe123210f1455
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35\|World / Primary Cells by Cluster	MAP1B PRSS12 TUBB TUBB2B KMT2A PHF14	1.70e-05	198	121	6	de5214a85fe017eb23d4aa8af624464f062ec57e
Drug	AC1NBBHE	TUBB TUBB2B ECH1 TUBB2A FBN2	5.00e-07	30	121	5	CID004490620
Drug	2,5-hexanedione	TUBB TUBB2B TUBB2A KCNA4 KCNH1 NGFR	5.20e-07	56	121	6	CID000008035
Drug	17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA	PIM2 MAP1B CCDC186 PLA2G3 PPM1E ATP8B2 RNASE4 JAG1 KMT2A	5.73e-07	182	121	9	998_UP
Drug	pioglitazone HCl; Up 200; 10uM; MCF7; HT_HG-U133A	FLT4 PIM2 MAP1B PRDX2 CRAT MEF2A KAZALD1 BAIAP3 GP2	1.16e-06	198	121	9	7083_UP
Drug	Dimenhydrinate [523-87-5]; Down 200; 8.6uM; HL60; HT_HG-U133A	TRIB2 PIM2 PRSS12 COLEC10 SYDE1 FBN2 MICAL2 JAG1 LRP2	1.21e-06	199	121	9	2400_DN
Drug	tetraethylenepentamine pentahydrochloride; Up 200; 10uM; MCF7; HG-U133A	TRIB2 SLIT2 SLC8B1 ANKRD28 SRPK3 KAZALD1 RIOK2 GP2 NPAT	1.21e-06	199	121	9	405_UP
Drug	CAY10397; Up 200; 10uM; MCF7; HT_HG-U133A	USP36 FLT4 PIM2 PRDX2 AGPS CRAT ZFPL1 KAZALD1 MUC5AC	1.26e-06	200	121	9	7082_UP
Drug	geldanamycin; Up 200; 1uM; MCF7; HT_HG-U133A_EA	MAP1B CCDC186 PLA2G3 PPM1E SYDE1 RNASE4 JAG1 EIF2AK3	4.28e-06	174	121	8	972_UP
Drug	17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA	MAP1B PLA2G3 PPM1E ATP8B2 RNASE4 SLC8B1 JAG1 EIF2AK3	5.49e-06	180	121	8	947_UP
Drug	MAPS	MAP1B NPEPPS TUBB TUBB2B PRDX2 TUBB2A SORT1 TGS1	8.49e-06	191	121	8	CID000066161
Drug	Etilefrine hydrochloride [534-87-2]; Down 200; 18.4uM; HL60; HT_HG-U133A	CCDC186 PPM1E TNFRSF10D ATP8B2 SORT1 IGFBP7 CLPTM1 PRR14L	9.16e-06	193	121	8	2930_DN
Drug	Ajmalicine hydrochloride [4373-34-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A	TRIB2 PIM2 MAP1B CHD4 KMT2A PHF14 TGS1 NPAT	1.10e-05	198	121	8	2898_DN
Drug	sodium 4-phenylbutyrate; Up 200; 1000uM; MCF7; HG-U133A	TRIB2 SYDE1 SLC8B1 KMT2A ANKRD28 SRPK3 KAZALD1 NPAT	1.14e-05	199	121	8	408_UP
Drug	NSC D-669356	TUBB TUBB2B APOH TUBB2A	1.21e-05	27	121	4	CID000178028
Drug	amiprophosmethyl	TUBB TUBB2B AGPS TUBB2A	2.14e-05	31	121	4	CID000100524
Drug	NSC376450	TUBB TUBB2B TUBB2A MUC5AC	3.11e-05	34	121	4	CID000005605
Drug	thapsigargin; Up 200; 0.1uM; MCF7; HT_HG-U133A	USP36 MAP1B PLA2G3 PPM1E RNASE4 EIF2AK3 TRIB1	3.53e-05	170	121	7	7053_UP
Drug	Insulin, porcine	HLA-DQA2 IGFBP7 LRP2	4.03e-05	13	121	3	DB00071
Drug	AC1O5Y0F	MAP1B TUBB TUBB2B TUBB2A	4.38e-05	37	121	4	CID006442852
Drug	DTAF	DSG3 TUBB TUBB2B TUBB2A	4.38e-05	37	121	4	CID000123934
Drug	Ethynodiol diacetate [297-76-7]; Down 200; 10.4uM; HL60; HT_HG-U133A	TRIB2 PRDX2 MEF2A ATP8B2 P4HA1 KMT2A TGS1	6.69e-05	188	121	7	3102_DN
Drug	Quinacrine dihydrochloride dihydrate [6151-30-0]; Up 200; 7.8uM; MCF7; HT_HG-U133A	DSG3 CRAT UBA7 FBN2 MICAL2 JAG1 PHF14	7.63e-05	192	121	7	3179_UP
Drug	chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HT_HG-U133A_EA	FLT4 ECH1 ZFPL1 HOXA3 UBA7 GNAT2 BAIAP3	7.89e-05	193	121	7	997_UP
Drug	CEP-701	PIM2 SORT1 NGFR KMT2A	7.98e-05	43	121	4	CID000126565
Drug	Cyclobenzaprine hydrochloride [6202-23-9]; Up 200; 12.8uM; MCF7; HT_HG-U133A	CCDC186 PLA2G3 SYDE1 UBA7 LRP2 KMT2A BAIAP3	8.41e-05	195	121	7	3268_UP
Drug	Gallamine triethiodide [65-29-2]; Up 200; 4.4uM; MCF7; HT_HG-U133A	PRSS12 CCDC186 TEX14 SYDE1 SORT1 MUC5AC BAIAP3	8.69e-05	196	121	7	2221_UP
Drug	S(+)-Terguride [37686-84-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A	CCDC186 ATP8B2 SORT1 SLC8B1 LRP2 KAZALD1 TGS1	8.97e-05	197	121	7	5400_DN
Drug	Urosiol [128-13-2]; Up 200; 10.2uM; HL60; HT_HG-U133A	MAP1B KIF26B CNTNAP1 COLEC10 COLQ ZNF749 GNAT2	8.97e-05	197	121	7	3105_UP
Drug	PNU-0251126 [267429-19-6]; Down 200; 1uM; PC3; HT_HG-U133A	MAP1B SYDE1 PHF14 KAZALD1 PRR14L GNAT2 BAIAP3	8.97e-05	197	121	7	3692_DN
Drug	Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A	FLT4 PIM2 PLA2G3 CRAT ATP8B2 KAZALD1 EPB41L2	8.97e-05	197	121	7	5477_DN
Drug	Fenbufen [36330-85-5]; Up 200; 15.8uM; PC3; HT_HG-U133A	PRSS12 TEX14 CRAT ARHGEF40 UBA7 BAIAP3 GP2	9.26e-05	198	121	7	3721_UP
Drug	Bufexamac [2438-72-4]; Down 200; 18uM; MCF7; HT_HG-U133A	PLA2G3 PRDX2 MEF2A MICAL2 LRP2 BCAR3 EPB41L2	9.26e-05	198	121	7	5515_DN
Drug	S(+)-Terguride [37686-84-3]; Down 200; 11.8uM; HL60; HT_HG-U133A	TNFRSF10D CR1 COLQ SLC8B1 JAG1 CLPTM1 KMT2A	9.55e-05	199	121	7	3082_DN
Drug	Cephapirin sodium salt [24356-60-3]; Up 200; 9uM; HL60; HT_HG-U133A	CCDC186 PLA2G3 COLEC10 TNFRSF10D MICAL2 KAZALD1 GNAT2	9.55e-05	199	121	7	2730_UP
Disease	ptosis (implicated_via_orthology)	TUBB TUBB2B TUBB2A	7.33e-06	10	118	3	DOID:0060260 (implicated_via_orthology)
Disease	tubulinopathy (implicated_via_orthology)	TUBB TUBB2B TUBB2A	7.33e-06	10	118	3	DOID:0112227 (implicated_via_orthology)
Disease	facial paralysis (implicated_via_orthology)	TUBB TUBB2B TUBB2A	7.33e-06	10	118	3	DOID:13934 (implicated_via_orthology)
Disease	complex cortical dysplasia with other brain malformations 7 (implicated_via_orthology)	TUBB TUBB2B TUBB2A	7.33e-06	10	118	3	DOID:0090132 (implicated_via_orthology)
Disease	cerebellar ataxia, mental retardation and dysequlibrium syndrome (implicated_via_orthology)	TUBB TUBB2B TUBB2A	1.34e-05	12	118	3	DOID:0050997 (implicated_via_orthology)
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	HLA-DQA1 APOH NFE2L3 TRIB1	3.48e-05	46	118	4	EFO_0008317, EFO_0008596, EFO_0020943
Disease	connective tissue disease (implicated_via_orthology)	FBN2 FBN3	4.74e-05	3	118	2	DOID:65 (implicated_via_orthology)
Disease	refractive error	CACNA1D ADAMTSL1 AGPS KCNA4 IGFBP7 KAZALD1 FBN3 NPAT	5.20e-05	326	118	8	MONDO_0004892
Disease	cholesterol to total lipids in small VLDL percentage	HLA-DQA1 APOH NFE2L3 TRIB1	5.25e-05	51	118	4	EFO_0022242
Disease	cholesterol to total lipids in very large VLDL percentage	HLA-DQA1 APOH NFE2L3 TRIB1	6.59e-05	54	118	4	EFO_0022244
Disease	free cholesterol to total lipids in medium VLDL percentage	HLA-DQA1 APOH NFE2L3 TRIB1	8.15e-05	57	118	4	EFO_0022284
Disease	triglycerides to total lipids in small VLDL percentage	HLA-DQA1 APOH NFE2L3 TRIB1	8.73e-05	58	118	4	EFO_0022338
Disease	female reproductive system disease	HLA-DQA1 TUBB TUBB2A	1.04e-04	23	118	3	EFO_0009549
Disease	triglycerides to total lipids in medium VLDL percentage	HLA-DQA1 APOH NFE2L3 TRIB1	1.21e-04	63	118	4	EFO_0022335
Disease	family history of Alzheimer’s disease	HLA-DQA1 CR1 CLPTM1 IL17RD	1.92e-04	71	118	4	EFO_0009268
Disease	TNF-related apoptosis-inducing ligand measurement	DSG3 KIF26B APOH C18orf21	2.03e-04	72	118	4	EFO_0008300
Disease	free cholesterol to total lipids in small VLDL percentage	HLA-DQA1 APOH NFE2L3 TRIB1	2.37e-04	75	118	4	EFO_0022287
Disease	pack-years measurement, systolic blood pressure	COLEC10 LRP1B LRP2	3.41e-04	34	118	3	EFO_0006335, EFO_0006526
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	HLA-DQA1 APOH NFE2L3	3.41e-04	34	118	3	EFO_0008317, EFO_0008596, EFO_0020944
Disease	intermediate density lipoprotein measurement	HLA-DQA1 APOH CLPTM1 TRIB1	4.19e-04	87	118	4	EFO_0008595
Disease	antiphospholipid syndrome (is_implicated_in)	HLA-DQA1 APOH	4.37e-04	8	118	2	DOID:2988 (is_implicated_in)
Disease	cholesteryl esters to total lipids in medium LDL percentage	HLA-DQA1 APOH TRIB1	4.39e-04	37	118	3	EFO_0022252
Disease	Alzheimer disease, educational attainment	HLA-DQA1 CR1 LRP1B KCNH1 CLPTM1 BCAR3	4.88e-04	247	118	6	EFO_0011015, MONDO_0004975
Disease	cholesterol in very small VLDL measurement	HLA-DQA1 APOH TRIB1	5.53e-04	40	118	3	EFO_0022231
Disease	supraventricular ectopy	KIF6 TRIB2	5.60e-04	9	118	2	EFO_0009277
Disease	cholesteryl ester measurement, intermediate density lipoprotein measurement	HLA-DQA1 APOH NFE2L3 TRIB1	5.62e-04	94	118	4	EFO_0008595, EFO_0010351
Disease	total cholesterol measurement, intermediate density lipoprotein measurement	HLA-DQA1 APOH NFE2L3 TRIB1	6.83e-04	99	118	4	EFO_0004574, EFO_0008595
Disease	uric acid measurement	FLT4 HLA-DQA1 JAG1 SELENOO LRP2 ANKRD28 GNAT2 TRIB1 EPB41L2	7.89e-04	610	118	9	EFO_0004761
Disease	free cholesterol measurement, intermediate density lipoprotein measurement	HLA-DQA1 APOH NFE2L3 TRIB1	8.21e-04	104	118	4	EFO_0008591, EFO_0008595
Disease	red blood cell density measurement	TRIB2 HLA-DQA1 TUBB CHD4 CRAT ATP8B2 ARHGEF40 KCNA4 KCNH1 JAG1 TRIB1	8.23e-04	880	118	11	EFO_0007978
Disease	uveitis (implicated_via_orthology)	HLA-DQA1 HLA-DQA2	8.52e-04	11	118	2	DOID:13141 (implicated_via_orthology)
Disease	bone density	ADAMTSL1 HLA-DQA1 CHD4 COLEC10 FBN2 JAG1 TNFRSF19	9.73e-04	388	118	7	EFO_0003923
Disease	free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement	HLA-DQA1 APOH NFE2L3 TRIB1	1.01e-03	110	118	4	EFO_0008317, EFO_0008591, EFO_0008596
Disease	autoimmune thyroiditis (is_implicated_in)	HLA-DQA1 LRP2	1.02e-03	12	118	2	DOID:7188 (is_implicated_in)
Disease	anti-Epstein Barr virus antibody measurement	HLA-DQA1 PHF14	1.02e-03	12	118	2	EFO_0009273
Disease	phospholipids in IDL measurement	HLA-DQA1 APOH TRIB1	1.19e-03	52	118	3	EFO_0022164
Disease	ocular sarcoidosis	KIF26B HLA-DQA1 FBN2 LRP2	1.23e-03	116	118	4	EFO_0010723
Disease	triglycerides to total lipids in very large VLDL percentage	HLA-DQA1 APOH TRIB1	1.26e-03	53	118	3	EFO_0022340
Disease	cholesteryl esters to total lipids in very large VLDL percentage	APOH NFE2L3 TRIB1	1.26e-03	53	118	3	EFO_0022258
Disease	Alzheimer disease, family history of Alzheimer’s disease	HLA-DQA1 CR1 CLPTM1 IL17RD	1.35e-03	119	118	4	EFO_0009268, MONDO_0004975
Disease	ferritin measurement	TRIB2 KCNA4 SETD7 TRIB1	1.35e-03	119	118	4	EFO_0004459
Disease	GDH/6PGL endoplasmic bifunctional protein measurement	HLA-DQA1 APOH	1.40e-03	14	118	2	EFO_0801619
Disease	free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	HLA-DQA1 APOH ADH5 NFE2L3 P4HA1 TRIB1	1.41e-03	303	118	6	EFO_0004612, EFO_0020945
Disease	apolipoprotein B measurement	HLA-DQA1 NPEPPS APOH SORT1 NFE2L3 KCNA4 IGFBP7 CLPTM1 TRIB1	1.41e-03	663	118	9	EFO_0004615
Disease	triglycerides in large VLDL measurement	HLA-DQA1 APOH TRIB1	1.48e-03	56	118	3	EFO_0022178
Disease	essential hypertension, age at diagnosis	HLA-DQA1 CHORDC1 REXO1	1.48e-03	56	118	3	EFO_0004918, MONDO_0001134
Disease	triglycerides in very large VLDL measurement	HLA-DQA1 APOH TRIB1	1.48e-03	56	118	3	EFO_0022325
Disease	triglycerides in chylomicrons and extremely large VLDL measurement	HLA-DQA1 APOH TRIB1	1.48e-03	56	118	3	EFO_0022316
Disease	cholesteryl esters to total lipids in large VLDL percentage	HLA-DQA1 APOH NFE2L3	1.48e-03	56	118	3	EFO_0022250
Disease	severe aplastic anemia	HLA-DQA2 FBN2	1.61e-03	15	118	2	EFO_0006927
Disease	triglycerides in VLDL measurement	HLA-DQA1 APOH TRIB1	1.72e-03	59	118	3	EFO_0022326
Disease	concentration of chylomicrons and extremely large VLDL particles measurement	HLA-DQA1 APOH TRIB1	1.72e-03	59	118	3	EFO_0022260
Disease	free cholesterol to total lipids in very large VLDL percentage	HLA-DQA1 APOH TRIB1	1.72e-03	59	118	3	EFO_0022289
Disease	congenital heart disease	MAP1B PRSS12 LRP1B	1.72e-03	59	118	3	EFO_0005207
Disease	cholesterol in chylomicrons and extremely large VLDL measurement	HLA-DQA1 APOH TRIB1	1.81e-03	60	118	3	EFO_0021898
Disease	Tetralogy of Fallot	FLT4 JAG1	1.83e-03	16	118	2	C0039685
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	HLA-DQA1 APOH TRIB1	1.89e-03	61	118	3	EFO_0008317, EFO_0008596, EFO_0020946
Disease	total lipids in chylomicrons and extremely large VLDL measurement	HLA-DQA1 APOH TRIB1	1.99e-03	62	118	3	EFO_0022306
Disease	total lipids in very large VLDL measurement	HLA-DQA1 APOH TRIB1	1.99e-03	62	118	3	EFO_0022313
Disease	free cholesterol in chylomicrons and extremely large VLDL measurement	HLA-DQA1 APOH TRIB1	1.99e-03	62	118	3	EFO_0022263
Disease	Colorectal Carcinoma	ACACA SELENBP1 MAP1B CD248 PPM1E OBSCN TUBB2A FBN2 LRP2	2.08e-03	702	118	9	C0009402
Disease	cholesterol to total lipids in medium VLDL percentage	HLA-DQA1 APOH TRIB1	2.08e-03	63	118	3	EFO_0022239
Disease	phospholipids in chylomicrons and extremely large VLDL measurement	HLA-DQA1 APOH TRIB1	2.08e-03	63	118	3	EFO_0022292
Disease	cholesteryl ester measurement, very low density lipoprotein cholesterol measurement	HLA-DQA1 APOH NFE2L3 CLPTM1 TRIB1	2.15e-03	225	118	5	EFO_0008317, EFO_0010351
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	HLA-DQA1 NPEPPS APOH NFE2L3 TRIB1	2.15e-03	225	118	5	EFO_0008317, EFO_0020947
Disease	cholesteryl esters to total lipids in medium VLDL percentage	HLA-DQA1 APOH TRIB1	2.17e-03	64	118	3	EFO_0022253
Disease	phospholipids:total lipids ratio	HLA-DQA1 APOH NFE2L3 CLPTM1 TRIB1	2.23e-03	227	118	5	EFO_0020946
Disease	free cholesterol measurement, low density lipoprotein cholesterol measurement	HLA-DQA1 APOH NFE2L3 TRIB1	2.27e-03	137	118	4	EFO_0004611, EFO_0008591
Disease	Myeloid Leukemia	PRDX2 KMT2A	2.33e-03	18	118	2	C0023470
Disease	Leukemia, Monocytic, Chronic	PRDX2 KMT2A	2.33e-03	18	118	2	C0023466
Disease	gestational age	HLA-DQA1 NFE2L3 SLIT2 TRIB1	2.33e-03	138	118	4	EFO_0005112
Disease	hematocrit	TRIB2 ACACA HLA-DQA1 CR1 ARHGEF40 KCNA4 KCNH1 JAG1 LRP2 HDGFL2 TRIB1	2.47e-03	1011	118	11	EFO_0004348
Disease	total lipids in large VLDL	HLA-DQA1 APOH TRIB1	2.48e-03	67	118	3	EFO_0022175
Disease	cataract	TRIB2 HLA-DQA1 LRP1B JAG1	2.52e-03	141	118	4	MONDO_0005129
Disease	triglycerides to phosphoglycerides ratio	HLA-DQA1 APOH TRIB1	2.59e-03	68	118	3	EFO_0022327
Disease	colorectal cancer, inflammatory bowel disease	ATP8B4 HLA-DQA1	2.59e-03	19	118	2	EFO_0003767, MONDO_0005575
Disease	congenital heart disease (implicated_via_orthology)	USP36 LRP2 KMT2A	2.70e-03	69	118	3	DOID:1682 (implicated_via_orthology)
Disease	very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	HLA-DQA1 APOH NFE2L3 CLPTM1 TRIB1	2.79e-03	239	118	5	EFO_0008317, EFO_0020945
Disease	glaucoma (is_marker_for)	SELENBP1 MUC5AC	2.87e-03	20	118	2	DOID:1686 (is_marker_for)
Disease	Deaf Mutism	CACNA1D JAG1	2.87e-03	20	118	2	C4082305
Disease	Deafness, Acquired	CACNA1D JAG1	2.87e-03	20	118	2	C0751068
Disease	Hearing Loss, Extreme	CACNA1D JAG1	2.87e-03	20	118	2	C0086395
Disease	Complete Hearing Loss	CACNA1D JAG1	2.87e-03	20	118	2	C0581883
Disease	Bilateral Deafness	CACNA1D JAG1	2.87e-03	20	118	2	C3665473
Disease	Prelingual Deafness	CACNA1D JAG1	2.87e-03	20	118	2	C0011052
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	FLT4 ASB15 LRP1B RIOK2	3.00e-03	148	118	4	C0279702
Disease	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement	HLA-DQA1 APOH NFE2L3 TRIB1	3.14e-03	150	118	4	EFO_0004611, EFO_0020947
Disease	free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage	APOH TRIB1	3.17e-03	21	118	2	EFO_0022277
Disease	urate measurement	CD248 HLA-DQA1 TEX14 REXO1 KMT5B JAG1 LRP2 ANKRD28 GNAT2 EPB41L2	3.21e-03	895	118	10	EFO_0004531
Disease	nasopharyngeal neoplasm	FLT4 HLA-DQA1 KMT2A TNFRSF19	3.22e-03	151	118	4	EFO_0004252
Disease	platelet component distribution width	FLT4 NPEPPS TUBB PRDX2 ZNF496 METTL13 ANKRD28 TRIB1 TGS1	3.37e-03	755	118	9	EFO_0007984
Disease	low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	HLA-DQA1 APOH NFE2L3 TRIB1	3.37e-03	153	118	4	EFO_0004611, EFO_0020946
Disease	low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	HLA-DQA1 APOH NFE2L3 TRIB1	3.37e-03	153	118	4	EFO_0004611, EFO_0020944
Disease	Prostatic Neoplasms	PRDX2 LRP1B RNASE4 IGFBP7 NGFR LRP2 KMT2A IL17RD	3.39e-03	616	118	8	C0033578
Disease	Malignant neoplasm of prostate	PRDX2 LRP1B RNASE4 IGFBP7 NGFR LRP2 KMT2A IL17RD	3.39e-03	616	118	8	C0376358
Disease	Malignant neoplasm of breast	NID2 KIF6 ZSWIM5 PPM1E OBSCN RRAD HOXA3 IGFBP7 KCNH1 JAG1 BCAR3	3.90e-03	1074	118	11	C0006142
Disease	mean arterial pressure	USP36 CACNA1D ASB15 MEF2A REXO1 HOXA3 FBN2	4.00e-03	499	118	7	EFO_0006340

Protein segments in the cluster

Peptide	Gene	Start	Entry
QENYIPDHGGGEDSC	CCDC186	66	Q7Z3E2
DLTAFDGPYCNHDIG	CNTNAP1	986	P78357
HCSLAPCGEDYEEEG	ARHGEF40	1006	Q8TER5
TFGCHDGYSLDGPEE	APOH	231	P02749
CGHYPEESEDTVTDV	CFAP97	241	Q9P2B7
EGHSFELCPSEASPY	EIF2AK3	781	Q9NZJ5
GPTEDHTDDFLGCLN	BAIAP3	336	O94812
CLEEHYGTSPGQARE	BCAR3	261	O75815
HTDAYTLSGADPEGC	ADH5	46	P11766
GKEVEFGPSECYSHL	ADAM2	501	Q99965
GGFECYCSEGHELEA	CD248	331	Q9HCU0
YCSEGHELEADGISC	CD248	336	Q9HCU0
VTPLGVAAEYGHCDV	ASB15	211	Q8WXK1
GCTPLHYAATSDTDG	ANKRD28	471	O15084
GDSPIDFEDSAHVPC	ACACA	486	Q13085
VAEDGSCGLVYEHAA	CRAT	331	P43155
EGEPSDPYGHEDCVE	COLEC10	236	Q9Y6Z7
DPYGHEDCVEMLSSG	COLEC10	241	Q9Y6Z7
PHGLCYVETAELDGE	ATP8B4	156	Q8TF62
GAHYVESCDEDTEEG	C3orf70	196	A6NLC5
CPHGSGYTAEGRDVD	FBN3	2351	Q75N90
CGGEDIVADHVASYG	HLA-DQA1	21	P01909
PHGLCYIETAELDGE	ATP8B2	176	P98198
RPDTGDDAAGHGFCY	GMCL1	31	Q96IK5
EYAEHCTDEGFIPAC	NPAT	36	Q14207
DGPEAEAAGHTYDRS	RRAD	116	P55042
DSGYGIESCGHPIEV	DSG3	876	P32926
HEGVEDCDGSDFGYL	COLQ	411	Q9Y215
PGVYGDEQSEFVCHT	GJC3	41	Q8NFK1
CGGEDIVADHVASYG	HLA-DQA2	21	P01906
SHREDVSIACYPGGE	PRSS12	476	P56730
EGQLCDLDPSAHFYG	KAZALD1	86	Q96I82
DLDPSAHFYGHCGEQ	KAZALD1	91	Q96I82
DYSCEGDVPGILDLS	IL17RD	481	Q8NFM7
LDCPDGYDEGVHCQE	LRP1B	101	Q9NZR2
YDDSEDGGHTLGDPS	MAP1B	1991	P46821
SAALGADGEYHRPAC	HOXA3	36	O43365
TDDVRPQDCYHGAGE	MST1L	346	Q2TV78
SIESSCYSAGHIPDG	LRRC53	821	A6NM62
EQAAGSEHYDASPCS	KIF26B	206	Q2KJY2
YTEGLHENGVCCSDP	KMT5B	791	Q4FZB7
CAPGDLIYHAGESVD	KCNH5	571	Q8NCM2
DAGVYTCSAGPAREH	ADAMTSL1	941	Q8N6G6
GDYDPEEHGSIDLSE	EPB41L2	346	O43491
EASGVALGEAPDHSY	ECH1	41	Q13011
VCDEGAIGYCTDHES	NFE2L3	441	Q9Y4A8
PIEASSYGLDLDCGA	GP2	36	P55259
ECGYDLLDPRHEASS	KIF6	151	Q6ZMV9
HCAPGDLIYHAGESV	KCNH1	601	O95259
DGHPDCLYGSDEHNA	LRP2	1251	P98164
DDPCLATCAVYGDGH	MUC5AC	896	P98088
SPLSKEDAGEYECHA	IGFBP7	236	Q16270
KEHRGCDSPDPDTSY	MEF2A	91	Q02078
SYAPEGDEEIHATGF	NPEPPSL1	106	A6NEC2
AFQYTDEHGEVCPAG	PRDX2	161	P32119
VHEGCYGVDGESDSI	PHF14	346	O94880
EEGPRCGSSEDLHDS	HDGFL2	626	Q7Z4V5
AEHKPYICGDADSAS	PPM1E	406	Q8WY54
EDAGLYTCHVGSEET	OBSCN	2711	Q5VST9
SGEGDYSTRHAACPV	P4HA1	491	P13674
PGYAGDGHQCTDVDE	NID2	881	Q14112
LHSLGPEDEGVYHCA	IGSF8	531	Q969P0
VTCEEESPRAYHGAA	KLHL10	321	Q6JEL2
GKEISYACDTHPDRG	CR1	1796	P17927
DPGYLPHVYSEEGEC	CDH26	776	Q8IXH8
GITAASPSGEADEHY	KMT2A	3436	Q03164
DDEVAFQDLCPYGHG	FBN2	2146	P35556
DLCDGDTGEPRYTLH	METTL13	271	Q8N6R0
HLCEPGADGAETFAD	CHD4	1466	Q14839
SYAPEGDEEIHATGF	NPEPPS	106	P55786
DPHCLGEQEYFSSEE	CACNA1D	1836	Q01668
YLEAAARGLHDSCPG	C18orf21	6	Q32NC0
ESDYGGSEGSHTEPC	MICAL2	1176	O94851
CEETYETLDHGSEPG	PRR14L	76	Q5THK1
PPGYAGDHCERDIDE	JAG1	476	P78504
DFIRTNPDCHSDGGY	SLC8B1	66	Q6J4K2
NPDCHSDGGYLDYLE	SLC8B1	71	Q6J4K2
EGDNCRYSHDLSDSP	MKRN1	71	Q9UHC7
TSCEAGLLHGEEDYL	ARHGAP20	871	Q9P2F6
SGPDYDHVTGSDSED	SYDE1	671	Q6ZW31
ELSGDTHPGIYALDC	REXO1	1051	Q8N1G1
LAHSTDPEDYEDGCI	SORT1	621	Q99523
GAAFEELPHDGTCDE	TRIM44	6	Q96DX7
GDDYCDSPYSEHGTL	SRGAP1	711	Q7Z6B7
VDYGSDPNHRCFDGS	TEX14	76	Q8IWB6
DGYHSFECGSIDPLT	TMEM71	41	Q6P5X7
EDCEAGPYGHDTNHV	NBR1	241	Q14596
IYCGFDPTADSLHVG	YARS2	76	Q9Y2Z4
PCEDSFLPDTEGHTY	POMGNT1	561	Q8WZA1
GALLHDEPYTDFDGT	PIM2	186	Q9P1W9
LGIDYAEPSCADDGR	GNAT2	91	P19087
PYHCEAGAATDAEAT	SELENOO	626	Q9BVL4
LDDDGLPHGFCTVTY	SETD7	16	Q8WTS6
DPTGSYHGDSDLQLE	TUBB2A	31	Q13885
AHELRYPGGDCSSDI	SELENBP1	456	Q13228
EGTCVDTVYDHGADV	WDR17	641	Q8IZU2
CDHEEDVGLTCTGYT	SSC5D	861	A1L4H1
EPELTAAYGALCAHE	PLA2G3	76	Q9NZ20
EGSLPHSDDAGDYEQ	SLX4	971	Q8IY92
LATGDYLFEPHSGED	SRPK3	456	Q9UPE1
LKESGYCTGHEPDSL	AGPS	291	O00116
NSDGCYEHFAELDIP	CLPTM1	141	O96005
PETNSDDACTYHPGV	CHORDC1	16	Q9UHD1
EECPAGSHRSEYTGA	TNFRSF10D	81	Q9UBN6
VHPEETGGSDRYCNL	RNASE4	41	P34096
SDLDVCPLEDGNYGH	ZSWIM5	446	Q9P217
EHDGTHPEQGLYTCA	ZNF749	101	O43361
DDALSDKHGCPAYVS	TRIB1	236	Q96RU8
CEGDDEDTAFPPLHY	UBA7	996	P41226
CEECPDGTYSDEANH	NGFR	146	P08138
DGTYSDEANHVDPCL	NGFR	151	P08138
DDSLSDKHGCPAYVS	TRIB2	206	Q92519
DPTGSYHGDSDLQLE	TUBB2B	31	Q9BVA1
PHGALTECYDELGNR	UBTD2	101	Q8WUN7
ELATGDYLFEPHSGE	SRPK2	576	P78362
EYGELSEPSEEDHCS	FLT4	1336	P35916
DPTGTYHGDSDLQLD	TUBB	31	P07437
ITGGHYDVDCRLEDP	TMED7	66	Q9Y3B3
PGYVGEHCDIDFDDC	SLIT2	1066	O94813
GSDEYEDECPHLIAL	RIOK2	441	Q9BVS4
GDEDSQHGPYCTEEL	ZNF496	361	Q96IT1
SFCDSYPELTGEDIH	TNFRSF19	321	Q9NS68
GDLYECDSHGPVTDA	ZNF543	176	Q08ER8
EEEEGGYSCGTAESH	TGS1	61	Q96RS0
DRTPGLHGDCDDDKY	ZFPL1	221	O95159
SEHTYESCGDGVPAP	USP36	86	Q9P275
DHGDECSYTDLLPQD	KCNA4	146	P22459